Meeting
2016 ASCO Annual Meeting
Peritoneal mesothelioma: evaluation of chemotherapeutic agents used for HIPEC through the RENAPE database.
Authors
Brice Malgras
Department of Surgical Oncology, Hôpital Lariboisière, AP-HP, Paris, France
Brice Malgras , Etienne Gayat , Rea Lo Dico , Clarisse Eveno , Karine Pautrat , Thierry Andre , Marc Pocard
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Other GI Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 4101)
DOI
10.1200/JCO.2016.34.15_suppl.4101
Abstract #
4101
Poster Bd #
93
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Cytoreductive surgery and HIPEC in colorectal cancer peritoneal metastases (CRPM): Real-world outcomes in systemic anticancer treatment–naïve patients.
First Author: Nadina Tinsley
Poster
2017 Gastrointestinal Cancers Symposium
Evaluation of a cell viability assay based on cultures of CTICs to identify treatment options in third-line pancreatic cancer.
First Author: Mark Ricigliano
Poster
2016 Palliative and Supportive Care in Oncology Symposium
Efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with gastrointestinal and colorectal cancers.
First Author: Rudolph M. Navari
Poster
2015 ASCO Annual Meeting
Perioperative chemotherapy and cytoreductive surgery with versus without HIPEC in gastric cancer with limited peritoneal metastases: A randomized phase III study (GASTRIPEC).
First Author: Beate Rau